More Investing
View Older Stories View Newer Stories-
S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
-
B. Riley Securities Names Top Pick in Financial Services Sector
-
Circle stock dips as CFO Fox-Geen steps down and co-founder leaves board
-
RegenLab targets Nasdaq listing under ticker RGNA as revenues top $29 million
-
Moody’s raises BJ’s Wholesale outlook to positive on debt reduction
-
Moody’s upgrades Cushman & Wakefield rating to Ba3 on debt reduction
-
Moody’s upgrades Brinker to Ba1 on Chili’s growth and debt reduction
-
Rithm Capital earns S&P upgrade to ’B+’ following steady revenue diversification
-
S&P downgrades Cable One to ’B+’ on weakening broadband outlook
-
Canadian dollar faces near-term pressure as rate gap and trade risks widen
-
Oura IPO said to draw four times demand as orders near close
-
Viatris sues Novo Nordisk over generic Wegovy patent dispute
-
Humana surges: Barclays bets big on Medicare star ratings rebound
-
Fed’s Hammack says public’s inflation expectations could worsen
-
Investing.com’s stocks of the week
-
SK Hynix’s Solidigm said to mull IPO that could value unit at $150B
-
Anthropic supply-chain designation upheld in AI military dispute
-
Meta jury finds company misled New Mexico residents
-
Nscale secures $3.36 billion pre-IPO round as public debut looms
-
Webull working with regulators as AI trading evolves
-
CrowdStrike probe closed by US prosecutors without charges
-
Bill Gates demands federal AI guardrails, warns of "a billion deaths"
-
Cognition AI hits $1 billion run rate amid demand for coding software - Bloomberg
-
B. Riley’s Top Biotech Picks Ahead of 3Q26 Earnings Season
-
Mizuho bullish on Tower Semiconductor, points to AI optical growth
-
BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
-
Fed’s Schmid questions if AI ecosystem is "too-big-to-fail"
-
Adarx Pharmaceuticals allocates 55% of IPO to 10 investors
-
Canadian boards have an AI problem — what is it?
-
KeyBanc gets bearish on Comcast as broadband competition intensifies
-
HSBC cuts Twilio to Reduce, says Muse rally has gone too far
-
Stifel starts Almonty with $25 price target on Western tungsten expansion
-
CoreCivic shares slip following unexpected CEO transition
-
Nektar Therapeutics stock rises on $90M jury verdict vs Lilly
-
Tesla faces production challenges with Optimus robot hands, report says
-
Star Fashion Culture stock falls on $9.6M share offering
-
Bernstein sees downside risk to Apple's December quarter results
-
Regenxbio stock gains on positive gene therapy trial data
-
This Is The Top REIT Stock Stifel Analysts Are Backing Right Now
-
Atlas Energy stock surges on AI data center power deals
-
BofA says investors are increasingly worried about an AI boom-bust cycle
-
BASF proposes takeover of German chemical rival Evonik, Financial Times reports
-
Microsoft unveils unified Copilot, cedes consumer AI market to focus on enterprise
-
Nike dips as BofA downgrades stock on longer-than-expected turnaround
-
Hyperscalers need $300 billion in annual AI revenue to break even: Goldman
-
Bernstein unveils top European medtech stock picks to buy for H2
-
AI fears serious, but frontier slowdown unlikely: BMO
-
Cipher Digital stock jumps after extending Barber Lake lease
-
European AI-linked stocks rally After Anthropic’s $11.6 bln computing deal
-
Barclays asks if equity markets are nearing the boiling point
